Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CS-2606
- Development stage
- Preclinical
- Lead developer
- CanSino Biologics
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
CS-2606 is a multivalent mRNA-based vaccine candidate developed by CanSino Biologics for the prevention of influenza. The vaccine utilizes messenger RNA technology to encode specific influenza virus antigens, which, once translated by the host's cellular machinery, induce both protective humoral (antibody-mediated) and cellular immune responses against multiple strains of the influenza virus. This candidate represents CanSino's expansion of its vaccine portfolio into mRNA platforms. In 2024, CanSino Biologics established a collaboration with the National Institutes of Biotechnology Malaysia (NIBM) to co-develop this multivalent vaccine, aiming to address the global burden of seasonal and potentially pandemic influenza.
- Other names
- multivalent mRNA influenza vaccineCanSino mRNA influenza vaccine
Beyond the preview
Go deeper on CS-2606.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CS-2606.